|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 September 2000, Vol. 96, No. 5, pp. 1764-1771
HEMATOPOIESIS
Mcl-1 is a common target of stem cell factor and interleukin-5
for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt
pathways
Huei-Mei Huang,
Chang-Jen Huang, and
Jeffrey Jong-Young Yen
From the Institute of Biomedical Sciences, and
Institute of Biological Chemistry, Academia Sinica, and Graduate
Institute of Life Sciences, National Defense Medical Center, Taipei,
Taiwan.
Stem cell factor (SCF) has been suggested as essential for optimal
production of various hematopoietic lineages mainly because of its
apoptosis prevention function when it costimulates with other
cytokines. However, the underlying mechanism of this synergism of
apoptosis prevention is largely unknown. The present study examined the
expression of some Bcl-2 family members, including Bcl-2,
Bcl-XL, Mcl-1, and Bax, in response to cytokine
stimulation in TF-1 and JYTF-1 cells in which SCF costimulation is
differentially required for optimal proliferation. The results revealed
that only the expression of Mcl-1 highly correlated with the
antiapoptotic activity of interleukin-5 (IL-5) and the synergistic
effect of SCF. In TF-1 cells, the defect of IL-5 in apoptosis
suppression and Mcl-1 induction was associated with the incapability to
highly phosphorylate Janus kinases (JAK1, JAK2), signal transducer and activator of transcription-5 (STAT5), mitogen-activated protein kinase
(MAPK), and Akt/PKB, whereas SCF costimulation restored the potent
phosphorylation of MAPK and Akt/PKB, but not STAT5. The importance of
MAPK and Akt/PKB signaling pathways in regulating the expression of
Mcl-1 and cell survival was further supported by the observation that
inhibition of MEK by PD98059 or phosphatidylinositol-3 kinase (PI-3K)
by LY294002 independently resulted in the reduction of Mcl-1 expression
and loss of cell viability. Therefore, the data suggest that
Mcl-1 is a common antiapoptotic target of both early-stage
cytokine SCF and late-stage cytokine IL-5. Both MEK/MAPK and PI-3K/Akt
signaling pathways are essential in the regulation of Mcl-1 expression
and apoptosis prevention.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Allard, N. Figg, M. R. Bennett, and T. D. Littlewood
Akt Regulates the Survival of Vascular Smooth Muscle Cells via Inhibition of FoxO3a and GSK3
J. Biol. Chem.,
July 11, 2008;
283(28):
19739 - 19747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, P. Haviernik, K. D. Bunting, and Y.-C. Yang
Cited2 is required for normal hematopoiesis in the murine fetal liver
Blood,
October 15, 2007;
110(8):
2889 - 2898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-R. Lin, S.-F. Lee, C.-M. Hung, C.-L. Li, H.-F. Yang-Yen, and J. J. Y. Yen
Survival Factor Withdrawal-induced Apoptosis of TF-1 Cells Involves a TRB2-Mcl-1 Axis-dependent Pathway
J. Biol. Chem.,
July 27, 2007;
282(30):
21962 - 21972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Dolgachev, M. Thomas, A. Berlin, and N. W. Lukacs
Stem cell factor-mediated activation pathways promote murine eosinophil CCL6 production and survival
J. Leukoc. Biol.,
April 1, 2007;
81(4):
1111 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ito, C. R. Mantel, M.-K. Han, S. Basu, S. Fukuda, S. Cooper, and H. E. Broxmeyer
Mad2 is required for optimal hematopoiesis: Mad2 associates with c-Kit in MO7e cells
Blood,
March 1, 2007;
109(5):
1923 - 1930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R G Lea, L P Andrade, M T Rae, L T Hannah, C E Kyle, J F Murray, S M Rhind, and D W Miller
Effects of maternal undernutrition during early pregnancy on apoptosis regulators in the ovine fetal ovary
Reproduction,
January 1, 2006;
131(1):
113 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. K. Lee, C. R. Isham, S. H. Kaufman, and K. C. Bible
Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy
Mol. Cancer Ther.,
January 1, 2006;
5(1):
138 - 148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rahmani, E. M. Davis, C. Bauer, P. Dent, and S. Grant
Apoptosis Induced by the Kinase Inhibitor BAY 43-9006 in Human Leukemia Cells Involves Down-regulation of Mcl-1 through Inhibition of Translation
J. Biol. Chem.,
October 21, 2005;
280(42):
35217 - 35227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Han, L. A. Goldstein, B. R. Gastman, A. Rabinovitz, and H. Rabinowich
Disruption of Mcl-1{middle dot}Bim Complex in Granzyme B-mediated Mitochondrial Apoptosis
J. Biol. Chem.,
April 22, 2005;
280(16):
16383 - 16392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu, H.-W. Peng, Y.-S. Cheng, H. S. Yuan, and H.-F. Yang-Yen
Stabilization and Enhancement of the Antiapoptotic Activity of Mcl-1 by TCTP
Mol. Cell. Biol.,
April 15, 2005;
25(8):
3117 - 3126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Aichberger, M. Mayerhofer, M.-T. Krauth, H. Skvara, S. Florian, K. Sonneck, C. Akgul, S. Derdak, W. F. Pickl, V. Wacheck, et al.
Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides
Blood,
April 15, 2005;
105(8):
3303 - 3311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Opferman, H. Iwasaki, C. C. Ong, H. Suh, S.-i. Mizuno, K. Akashi, and S. J. Korsmeyer
Obligate Role of Anti-Apoptotic MCL-1 in the Survival of Hematopoietic Stem Cells
Science,
February 18, 2005;
307(5712):
1101 - 1104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Gardai, D. A. Hildeman, S. K. Frankel, B. B. Whitlock, S. C. Frasch, N. Borregaard, P. Marrack, D. L. Bratton, and P. M. Henson
xPhosphorylation of Bax Ser184 by Akt Regulates Its Activity and Apoptosis in Neutrophils
J. Biol. Chem.,
May 14, 2004;
279(20):
21085 - 21095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Moshynska, K. Sankaran, P. Pahwa, and A. Saxena
Prognostic Significance of a Short Sequence Insertion in the MCL-1 Promoter in Chronic Lymphocytic Leukemia
J Natl Cancer Inst,
May 5, 2004;
96(9):
673 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Jazirehi and B. Bonavida
Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis
Mol. Cancer Ther.,
January 1, 2004;
3(1):
71 - 84.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Karlsson, M. Engstrom, M. Jonsson, P. Karlberg, C. J.H. Pronk, J. Richter, and J.-I. Jonsson
Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genes
J. Leukoc. Biol.,
November 1, 2003;
74(5):
923 - 931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Haughn, R. G. Hawley, D. K. Morrison, H. von Boehmer, and D. M. Hockenbery
BCL-2 and BCL-XL Restrict Lineage Choice during Hematopoietic Differentiation
J. Biol. Chem.,
June 27, 2003;
278(27):
25158 - 25165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Nijhawan, M. Fang, E. Traer, Q. Zhong, W. Gao, F. Du, and X. Wang
Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation
Genes & Dev.,
June 15, 2003;
17(12):
1475 - 1486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Wang, M.-Z. Lai, and H.-F. Yang-Yen
Interleukin-3 Stimulation of mcl-1 Gene Transcription Involves Activation of the PU.1 Transcription Factor through a p38 Mitogen-Activated Protein Kinase-Dependent Pathway
Mol. Cell. Biol.,
March 15, 2003;
23(6):
1896 - 1909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Sun, H. Matta, and P. M. Chaudhary
The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation
Blood,
March 1, 2003;
101(5):
1956 - 1961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Hartley, R. A. L. Bayne, L. L. L. Robinson, N. Fulton, and R. A. Anderson
Developmental Changes in Expression of Myeloid Cell Leukemia-1 in Human Germ Cells during Oogenesis and Early Folliculogenesis
J. Clin. Endocrinol. Metab.,
July 1, 2002;
87(7):
3417 - 3427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Alam and M. Gorska
Genomic Microarrays . Arraying Order in Biological Chaos?
Am. J. Respir. Cell Mol. Biol.,
October 1, 2001;
25(4):
405 - 408.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Ballif and J. Blenis
Molecular Mechanisms Mediating Mammalian Mitogen-activated Protein Kinase (MAPK) Kinase (MEK)-MAPK Cell Survival Signals
Cell Growth Differ.,
August 1, 2001;
12(8):
397 - 408.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Z. Carter, M. Milella, D. C. Altieri, and M. Andreeff
Cytokine-regulated expression of survivin in myeloid leukemia
Blood,
May 1, 2001;
97(9):
2784 - 2790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Domen and I. L. Weissman
Hematopoietic Stem Cells Need Two Signals to Prevent Apoptosis; BCL-2 Can Provide One of These, Kitl/c-Kit Signaling the Other
J. Exp. Med.,
December 11, 2000;
192(12):
1707 - 1718.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Miao, X.-K. Tong, G. K. Chan, D. Panda, P. S. McPherson, and D. Goltzman
Parathyroid Hormone-related Peptide Stimulates Osteogenic Cell Proliferation through Protein Kinase C Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway
J. Biol. Chem.,
August 17, 2001;
276(34):
32204 - 32213.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|